Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps  Latest publication
3,3'-(Biphenyl-4,4'-diyldidiazene-2,1-diyl)bis(4-aminonaphthalene-1-sulfonic acid)
Potential treatment - theoretical effect Experimental Antiviral Mar/26/2021
COV2-2130
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2022
N(4)-Hydroxycytidine
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/26/2022
CoV2-06
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/20/2021
5-(Acryloylamino)-2-methyl-N-[(1R)-1-(naphthalen-1-yl)ethyl]benzamide
Potential treatment - pre-clinical evidence Experimental Antiviral Feb/02/2021
mAb Beta-54
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 253
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
S2H97
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
(-)-Gallocatechin gallate
Potential treatment - pre-clinical evidence Natural product Antiviral Apr/09/2021
Spectinomycin
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Pyronaridine
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
N-(1,3-Benzodioxol-5-ylmethyl)-6H-indolo[2,3-b]quinoxaline-2-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Dec/04/2020
Maprotiline
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021
ACE2-GpA-RBC
Potential treatment - pre-clinical evidence Experimental Antiviral Mar/10/2021
Remdesivir
Approved by FDA Experimental Antiviral Jan/18/2023
Loperamide
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021
Levothyroxine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Feb/01/2021
Ribavirin
Recommended by China's NHC Guidelines Used to treat other disease Antiviral Mar/25/2021
Topotecan
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/30/2021
Pentamidine
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021